TIL Therapies market 2023 – Industry Growth by 2035
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global TIL Therapy Market (2nd Edition), 2023-2035.”
The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:
§ A detailed assessment of the current market landscape of TIL therapy.
§ A detailed analysis of completed, ongoing and planned clinical studies related to TIL-based therapies.
§ An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to TIL-based therapies.
§ Elaborate profiles of mid- to late-stage clinical products (phase I/II or above).
§ An analysis of various type of partnership that have been inked between several stakeholders in the domain of TIL therapies.
§ An analysis of the investments that have been made into companies that have proprietary TIL-based products / technologies.
§ An in-depth analysis of patents related to TIL-based therapies, filed / granted till 2022.
§ A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.
§ An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.
§ Elaborate profiles of the several leading players in the domain of TCR cell therapies.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
Target Indication(s)
§ Melanoma
§ Head and Neck Carcinoma
§ Chronic Lymphocytic Leukemia
§ Sarcoma
§ Hepatocellular Carcinoma
§ Breast Cancer
§ Acute Myeloid Leukemia
§ Cervical Carcinoma
Key Geographical Regions
§ North America
§ Europe
§ Asia Pacific
§ Latin America
§ Middle East and North Africa
§ Rest of the World
The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), details about TIL-based product(s), such as information on status of development, technology portfolio (if available), recent developments related to TIL-based therapies and manufacturing capabilities of the players.
§ Cellectis
§ Cellular Biomedicine Group
§ Iovance Biotherapeutics
§ Lytix Biopharma
§ Phio Pharmaceuticals
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/til-therapies-market.html
News article
Learn from experts: do you know about these emerging industry trends?
Agricultural Biologicals: An Answer to a Sustainable Future
The Future Of Healthcare: Wearable Injectors Unveiled
Top 5 CAR T Cell Therapy Companies to Look Out for in the Next Decade
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Contact:
Ben Johnson
+1 (415) 800 3415
